About
Our mission is to provide a highly differentiated minimally-invasive surgical solution designed to customize the visual outcome of the pseudophakic eye. Primary product is the AccuraSee Intraocular Pseudophakic Contact Lens (IOPCL) invented by Kevin Cady, CEO and Founder of OnPoint Vision, Inc.
Technologies
Outlook
Google Tag Manager
WordPress.org
Google Font API
reCAPTCHA
Apache
Mobile Friendly
Android
Remote
AI
Keywords
ophthalmic surgical device
intraocular lenses
treatment for age related macular degeneration
ophthalmology
customized pseudophakic vision
medical equipment manufacturing
healthcare equipment & supplies
b2c
retinal disease treatment
d2c
biocompatible silicone
ophthalmology innovation
vision recovery
macular degeneration lens
accurasee lens
refractive surgery innovation
clinical trials
refractive error correction
intraocular lens
pseudophakic contact lens
medical equipment and supplies manufacturing
healthcare technology
minimally-invasive surgery
ophthalmic surgical instruments
custom intraocular lens
fda approval process
vision restoration device
amd clinical study
iopcl
customizable intraocular lens
Company Information
-
Employees 10
-
Founded 2019
Location
6a Liberty, Aliso Viejo, California, United States, 92656-3829
